GL1X · GenesisL1 explorer

MolNFT v1 · #28979 · protein

The crystal structure of the PSI/HYBRID domain/ I-EGF1 segment from the human integrin BETA2 at 1.8 resolution

1YUK · Integrin beta-2 a chain: “The crystal structure of the PSI/HYBRID domain/ I-EGF1 segment from the human integrin BETA2 at 1.8 resolution”. X-ray diffraction, 1 ligand (NDG), 1 pocket (best druggability 0.39). MolNFT v1 #28979 on…

PDB
1YUK
Type
protein
Length
214 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrin beta-2 a chain; Integrin beta-2 B chain
UniProt
P05107
Ligands
NDG
Pockets
1 · best druggability 0.39

Structure

x-ray diffraction · 2 distinct chains · 12% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegrin beta-2 a chainprotein9419% helix, 29% strandP05107
BIntegrin beta-2 B chainprotein1206% helix, 45% strandP05107

Ligands and binding sites

  • NDG · 2-acetamido-2-deoxy-alpha-D-glucopyranose · sugar · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1500.390.8213empty

Interfaces

1 interface between chains.

  • A–B · 1975 Ų buried · 30 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 9 disulfide (disulfide).

Compared structures

  • 1YUK · The crystal structure of the PSI/Hybrid domain/ I-EGF1 segment from the human integrin… · the same entry in another collection · chain A against A, TM-score 1.00
  • P05107 · AlphaFold monomer V2.0 prediction for integrin beta-2 (P05107) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.